Breathing Exercise for Chronic Pain Management in Breast Cancer Survivors
An Evidence-based Breathing Exercise Intervention Protocol for Chronic Pain Management in Breast Cancer Survivors: A Preliminary Randomized Controlled Trial
1 other identifier
interventional
72
1 country
1
Brief Summary
The study will follow the MRC Framework to develop an evidence-based BE intervention protocol to help breast cancer survivors with better management of cancer-related chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Jan 2023
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2022
CompletedFirst Posted
Study publicly available on registry
February 25, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 12, 2023
CompletedFebruary 16, 2024
February 1, 2024
7 months
February 3, 2022
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Feasibility: Time taken to recruit planned sample
The time that was taken to recruit the planned sample size of participants
Immediately after the allocation of the last subject
Feasibility: Referral rate
The number of referrals made by clinicians in different departments divided by all referrals
Immediately after the referral of the last subject
Feasibility: Recruitment rate
Proportion of subjects who participated in the study from all subjects eligible for participation
Immediately after the recruitment of the last subject
Feasibility: Retention rate
Proportion of participants who completed the whole study divided by all subjects who enrolled in the study
At the follow-up assessment 4 weeks after the intervention completion (T3)
Feasibility: Dropout rate
The number of subjects who dropped out after randomization divided by all subjects who enrolled in the study
At the follow-up assessment 4 weeks after the intervention completion (T3)
Reasons for dropping out
Feedback from the dropout subjects to identify their reasons for dropping out
Immediately once a dropout occurs
Feasibility of the questionnaires
The percentage of missing values for each item of the scales used, including the Brief Pain Inventory (BPI), Quality of life Cancer Survivors Version (QOL-CSV), Functional Assessment Cancer Therapy-Breast (FACT-B), and Hospital Anxiety and Depression Scale (HADS)
At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Feasibility: Adherence rates
the percentage of BE sessions performed by participants divided by the total number of BE sessions required
Immediately after completion of the 4-week intervention (T2)
Participants' feedback
Participants' feedback on and satisfaction with the intervention using a specifically designed feedback form
Immediately after completion of the 4-week intervention (T2)
Adverse events associated with the intervention
Data will be collected from the participants' BE logbooks and supplemented by information collected during weekly telephone contact
Immediately once an adverse event occurs
Secondary Outcomes (4)
Chronic pain
At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Quality of life of breast cancer survivors ( using tool 1)
At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Quality of Life of breast cancer survivors ( using tool 2)
At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Anxiety and Depression
At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Study Arms (2)
Intervention group
EXPERIMENTALParticipants in the intervention group will receive breathing exercise training, pain information booklet, and usual care.
Control group
NO INTERVENTIONParticipants in the control group will receive pain information booklet and usual care.
Interventions
Participants will receive breathing exercise training, and a 4-week self exercise
Eligibility Criteria
You may qualify if:
- female breast cancer survivors ≥18 years age;
- has a confirmed diagnosis of breast cancer at stage I, II or IIIa;
- has been experiencing pain since cancer diagnosis constantly or intermittently for ≥3 months, with the average pain intensity in the last seven days on a numerical scale ≥4/10 ("0" indicates no pain and "10" indicates the worst pain);
- has completed active anticancer treatment (such as chemotherapy, radiotherapy, surgery) for at least three months;
- agrees to participate in the research and is willing to give informed consent;
- can read and understand Mandarin Chinese.
You may not qualify if:
- extremely weak and unable to perform the breathing exercises;
- mentally incapable (i.e., unable to follow the study instructions);
- has scheduled pain management interventions, such as having a procedure or operation;
- receiving other pain relief treatments, such as acupuncture, yoga, qigong, exercise program, etc.;
- has any pre-existing chronic pain conditions before cancer diagnosis, such as arthritis, rheumatoid arthritis, chronic low back pain, migraines, trigeminal neuralgia, fibromyalgia, joint dysfunction, Complex Regional Pain Syndrome, endometriosis, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Hospital Of Southwest Medical University
Luzhou, Sichuan, 646000, China
Related Publications (1)
Wang H, Tan JB, Wang T, Liu XL, Bressington D, Zheng SL, Huang HQ. Feasibility and potential effects of breathing exercise for chronic pain management in breast cancer survivors: study protocol of a phase II randomised controlled trial. BMJ Open. 2022 Dec 14;12(12):e064358. doi: 10.1136/bmjopen-2022-064358.
PMID: 36517097DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Professor Jing-Yu (Benjamin) Tan, PhD
Charles Darwin University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2022
First Posted
February 25, 2022
Study Start
January 1, 2023
Primary Completion
August 12, 2023
Study Completion
August 12, 2023
Last Updated
February 16, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
It needs to get the participants' consent if the data is shared with other researchers.